Trials / Terminated
TerminatedNCT00378495
Miltefosine for Brazilian Visceral Leishmaniasis
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- AB Foundation · Academic / Other
- Sex
- All
- Age
- 2 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Miltefosine will be administered to Brazilian patients with kala azar
Detailed description
Miltefosine will be administered to Brazilian patients with kala azar. Both pediatric and adult patients will be studied. Patients will be followed for 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Miltefosine: initially 2.5 mg/kg/day for 28 days |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2007-04-01
- Completion
- 2007-10-01
- First posted
- 2006-09-20
- Last updated
- 2016-07-12
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00378495. Inclusion in this directory is not an endorsement.